UNDBIO research efforts are geared towards accelerating access to affordable Insulin, Insulin Analogs & other Biosimilars (Monoclonal Antibodies).
Our focus is to develop affordable products and market tough-to-make products which are likely to be very expensive.
Our Unique strength and capabilities allow us to improve accessibility of these medicines.
Our Patient Centric approach will best address the unmet needs of the Patients
Our R&D strives towards UNDBIO Philosophy of "Saving Human Lives"
Pathway to Success
Development of new products with Intellectual property
Acquire skills. knowledge, and access to facilities, expertise and potentially new ideas that would bring synergy to the portfolio
Build a strong reputation and partnerships across the globe with strong scientific acumen which results in commercial success of the products